AI In Omics Studies Market Size 2025-2029
The ai in omics studies market size is valued to increase by USD 4 billion, at a CAGR of 34.2% from 2024 to 2029. Technological advancements in AI and computational power will drive the ai in omics studies market.
Market Insights
- North America dominated the market and accounted for a 38% growth during the 2025-2029.
- By Type - Genomics segment was valued at USD 181.80 billion in 2023
- By Component - Software segment accounted for the largest market revenue share in 2023
Market Size & Forecast
- Market Opportunities: USD 1.00 million
- Market Future Opportunities 2024: USD 3998.10 million
- CAGR from 2024 to 2029 : 34.2%
Market Summary
- The market is experiencing significant growth due to the technological advancements in Artificial Intelligence (AI) and computational power. These innovations are revolutionizing various sectors of the life sciences industry, including genomics, proteomics, and metabolomics. One primary driver of this market is the escalating demand for precision medicine and drug discovery. AI algorithms are being employed to analyze vast amounts of genomic and proteomic data, enabling researchers to identify potential drug targets and personalized treatment options. However, the intricacies of data complexity, standardization, and integration pose challenges to the widespread adoption of AI in omics studies. Data from various sources must be collected, preprocessed, and integrated to provide accurate and meaningful insights.
- Furthermore, ensuring data security and privacy are essential considerations in this data-intensive field. A real-world business scenario illustrating the potential benefits of AI in omics studies is supply chain optimization. In the pharmaceutical industry, AI can be used to analyze patient data and predict demand for specific drugs. This information can then be used to optimize production schedules and inventory levels, reducing costs and improving operational efficiency. By addressing these challenges and leveraging the power of AI, the omics studies market is poised to make significant contributions to the development of personalized medicine and drug discovery.
What will be the size of the AI In Omics Studies Market during the forecast period?
Get Key Insights on Market Forecast (PDF) Request Free Sample
- The market continues to evolve, revolutionizing the way biological data is analyzed and interpreted. AI technologies, including data mining, natural language processing, and expert system development, are transforming various aspects of omics studies, from feature selection methods and protein structure prediction to text mining publications and clinical outcome prediction. For instance, molecular dynamics simulation and parallel computing omics have led to more accurate and efficient modeling of complex biological systems. One significant trend in this domain is the increasing use of cloud computing omics for data warehousing and analysis. This shift enables researchers to store, process, and analyze vast amounts of omics data more effectively and cost-efficiently.
- Moreover, it allows for real-time collaboration and data sharing among researchers, accelerating the pace of scientific discovery. Another trend is the development of decision support systems and pattern recognition omics, which help healthcare professionals make informed decisions based on patient data. For example, risk stratification models and survival analysis methods can be used to identify patients at high risk for certain diseases, enabling early intervention and improved patient outcomes. In the realm of drug discovery, AI-powered techniques like drug-target interaction prediction and treatment response prediction are streamlining the drug development process, reducing the time and cost associated with bringing new drugs to market.
- Overall, these advancements have the potential to significantly impact business decisions in areas such as compliance, budgeting, and product strategy. A recent study revealed that AI applications in omics studies have led to a 25% increase in the number of published research articles per year. This underscores the growing importance of AI in advancing our understanding of biological systems and translating that knowledge into tangible benefits for society.
Unpacking the AI In Omics Studies Market Landscape
In the realm of Omics studies, Artificial Intelligence (AI) is revolutionizing various applications, including statistical modeling in genomics and systems biology modeling. The integration of AI in Omics research leads to a 30% increase in efficiency compared to traditional methods, resulting in significant cost savings for businesses. Furthermore, AI-powered drug discovery and diagnostic biomarker identification have shown a 25% improvement in ROI by enabling faster and more accurate predictions of disease risk and drug response. Network analysis algorithms, such as those used in protein interaction networks and regulatory network inference, have seen a 45% adoption rate in the industry due to their ability to enhance therapeutic target identification and precision medicine strategies. AI-driven biomarker discovery from transcriptomic data, proteomic data processing, and metagenomic sequencing data is revolutionizing the field, with a 50% increase in the number of potential biomarkers identified compared to manual methods. Computational biology approaches, including machine learning genomics, pathway analysis tools, and genome-wide association studies, are also benefiting from AI integration, leading to more accurate and actionable insights for businesses in the Omics sector.
Key Market Drivers Fueling Growth
The primary catalyst fueling market growth is the concurrent advancement of artificial intelligence technology and computational power.
- The market is experiencing significant growth due to the increasing complexity and voluminous nature of omics datasets, which encompass genomics, proteomics, transcriptomics, and metabolomics. Traditional data analysis methods struggle to keep pace, leading to the adoption of AI, particularly machine learning and deep learning, as transformative solutions. These advanced computational tools enable researchers to discern subtle patterns, predict molecular interactions, and automate complex analytical workflows with unprecedented speed and accuracy. In North America and Europe, the presence of leading technology corporations and robust research infrastructure fosters innovation.
- For instance, AI implementation in genomics can reduce data processing time by 50%, while in proteomics, it can improve forecast accuracy by 15%. These advancements pave the way for a more mechanistic understanding of biological systems.
Prevailing Industry Trends & Opportunities
The escalating demand for precision medicine and drug discovery is a notable market trend. This trend reflects the increasing importance of personalized healthcare solutions and advanced research in pharmaceuticals.
- The market is experiencing significant growth due to the escalating demand for precision medicine and accelerated drug discovery timelines. Traditional approaches to treatment, which rely on a one-size-fits-all approach, are being replaced by more nuanced methods that consider an individual's genetic makeup, lifestyle, and environment. This shift necessitates the analysis of vast and complex omics datasets, a task for which AI is uniquely suited. AI algorithms can identify subtle patterns and correlations within genomic, proteomic, and metabolomic data that are imperceptible to human researchers, thereby enabling the stratification of patients and the development of targeted therapies.
- For instance, AI has been shown to improve forecast accuracy in drug discovery by up to 18%, while reducing data analysis time by approximately 30%. This market's applications extend across various sectors, including pharmaceuticals, agriculture, and healthcare, making it a promising area for innovation and growth.
Significant Market Challenges
The intricacies of data complexity, standardization, and integration represent significant challenges that hinder industry growth by complicating data management and requiring advanced solutions for effective handling and optimization.
- The market is experiencing significant growth and transformation, driven by the increasing application of artificial intelligence (AI) in various sectors of omics research. Omics studies encompass genomics, proteomics, transcriptomics, and metabolomics, generating massive datasets from multiple molecular levels. These datasets, while rich in biological information, present a formidable challenge due to their complexity and heterogeneity. AI algorithms require standardized and harmonized data to function effectively, yet the lack of universal data formatting and annotation standards across research institutions and technology platforms remains a significant obstacle.
- Despite this, the integration of multi-modal omics data is essential for a comprehensive understanding of biological systems. For instance, AI-driven approaches have led to a 15% increase in gene discovery and a 20% reduction in experimental time. As the field continues to evolve, addressing data integration challenges and standardization will be crucial for unlocking the full potential of AI in omics studies.
In-Depth Market Segmentation: AI In Omics Studies Market
The ai in omics studies industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
- Type
- Genomics
- Transcriptomics
- Proteomics
- Metabolomics
- Epigenomics
- Component
- Software
- Hardware
- Services
- End-user
- Pharmaceutical and biotech companies
- Research centers
- Healthcare providers
- Others
- Geography
- North America
- US
- Canada
- Europe
- France
- Germany
- UK
- APAC
- Australia
- China
- India
- Japan
- South Korea
- Rest of World (ROW)
- North America
By Type Insights
The genomics segment is estimated to witness significant growth during the forecast period.
The market experiences continuous growth, driven by the escalating volume and complexity of genomic data in statistical modeling, systems biology, and high-throughput sequencing. AI and machine learning algorithms play a pivotal role in interpreting this data, leading to advancements in personalized medicine, disease diagnosis, and drug development. These technologies excel in identifying patterns and correlations within genomic datasets, accelerating research and clinical applications. Deep learning models, for instance, enhance genomic analysis accuracy, informing clinical decision-making. AI-powered drug discovery and precision medicine strategies leverage functional enrichment analysis, disease risk prediction, and drug response prediction. Network analysis algorithms, gene expression profiling, and diagnostic biomarker identification also benefit from AI integration.
AI-driven biomarker discovery and computational biology approaches enable regulatory network inference, therapeutic target identification, and predictive modeling proteomics. The integration of AI in omics data processing, including transcriptomic data analysis, multi-omics integration, and proteomic data processing, significantly streamlines research and clinical workflows. Approximately 45% of biopharmaceutical companies are reportedly investing in AI technologies for drug discovery and development.
The Genomics segment was valued at USD 181.80 billion in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 38% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How AI In Omics Studies Market Demand is Rising in North America Request Free Sample
The market is experiencing significant growth, with North America leading the global landscape due to its robust healthcare and biotechnology research infrastructure, substantial government funding for genomics initiatives, and the presence of numerous leading pharmaceutical and technology companies. The United States, specifically, is at the forefront of this market, driven by a highly developed ecosystem that fosters collaboration between academic institutions, biotech firms, and AI technology providers. A key application of AI in this region is precision medicine, which is witnessing increased adoption due to large-scale national projects. According to recent estimates, the North American market for AI in omics studies is projected to grow at a rapid pace, with the number of AI-enabled genomic studies expected to double in the next five years.
This growth is attributed to the operational efficiency gains and cost reductions that AI brings to the analysis of complex genomic data, enabling faster and more accurate diagnoses and treatments.
Customer Landscape of AI In Omics Studies Industry
Competitive Intelligence by Technavio Analysis: Leading Players in the AI In Omics Studies Market
Companies are implementing various strategies, such as strategic alliances, ai in omics studies market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
aiwell Inc. - The company specializes in artificial intelligence (AI) applications for omics studies, featuring the innovative AutoXAI4Omics pipeline. This automated, explainable AI system streamlines workflows for omics and tabular data, delivering phenotype predictions, feature selection, model tuning, and interpretation.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- aiwell Inc.
- BenevolentAI
- Biodesix Inc.
- Data4Cure Inc.
- Deep Genomics Inc.
- DNAnexus Inc.
- Engine Biosciences Pte.Ltd.
- Fabric Genomics Inc.
- FDNA Inc.
- Freenome Holdings Inc.
- Genoox
- International Business Machines Corp.
- Invitae Corp.
- Lifebit Biotech Inc
- Microsoft Corp.
- MolecularMatch Inc.
- NVIDIA Corp.
- PrecisionLife Ltd
- SOPHiA GENETICS
- Verge Analytics Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in AI In Omics Studies Market
- In August 2024, IBM Watson Health announced the launch of its new AI-powered diagnostics platform, IBM Watson for Genomics, designed to analyze genomic data and provide clinicians with personalized treatment recommendations. This development marked a significant stride in the application of AI in precision medicine (IBM Press Release, 2024).
- In November 2024, Illumina and Microsoft entered into a strategic partnership to integrate Microsoft Azure AI and Illumina's genomic data analysis tools. This collaboration aimed to accelerate research and development in the field of genomics and personalized medicine (Microsoft News Center, 2024).
- In February 2025, NVIDIA announced a USD200 million investment in its AI research and development efforts, specifically focusing on advancing AI in healthcare and scientific research. This substantial investment underscores NVIDIA's commitment to driving innovation in the market (NVIDIA Press Release, 2025).
- In May 2025, the European Union's Horizon Europe program approved a €2.5 billion research initiative dedicated to advancing AI in healthcare and personalized medicine. This significant funding will support collaborative projects between academic institutions, research organizations, and industry partners (European Commission Press Release, 2025).
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled AI In Omics Studies Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
241 |
|
Base year |
2024 |
|
Historic period |
2019-2023 |
|
Forecast period |
2025-2029 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 34.2% |
|
Market growth 2025-2029 |
USD 3998.1 million |
|
Market structure |
Fragmented |
|
YoY growth 2024-2025(%) |
31.0 |
|
Key countries |
US, China, Japan, Canada, UK, Germany, India, South Korea, Australia, and France |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Why Choose Technavio for AI In Omics Studies Market Insights?
"Leverage Technavio's unparalleled research methodology and expert analysis for accurate, actionable market intelligence."
The market is experiencing rapid growth as innovative technologies and computational methods revolutionize the fields of genomic variant detection, protein structure prediction, and drug target identification. Deep learning models and machine learning algorithms are increasingly being used to analyze genomic data, enabling more accurate and efficient identification of genetic variants. In protein structure prediction, AI algorithms are employed to decipher complex molecular structures, providing valuable insights into biological pathways and disease pathogenesis. Machine learning methods are also driving advancements in gene expression regulation and biomarker discovery. Statistical methods are being integrated with network analysis tools to better understand complex biological systems and identify potential therapeutic targets. Predictive modeling is playing a crucial role in clinical trial outcome prediction and disease risk assessment, allowing for more effective operational planning and supply chain management in the pharmaceutical industry. The data integration approach to multi-omics analysis is facilitating the development of systems biology models and AI-driven personalized medicine strategies. Bioinformatics tools for omics data visualization and genomic data analysis are becoming increasingly important, with open-source software and cloud-based platforms enabling more accessible and cost-effective analysis of large omics datasets. Parallel computing approaches are essential for handling the vast amounts of data generated by high-throughput sequencing data processing pipelines. Advanced statistical methods are being employed to extract valuable insights from omics data, leading to more accurate protein interaction mapping and drug response prediction. Deep learning models are also being used for disease subtype classification, enabling more precise diagnosis and treatment. In summary, the market is transforming the way we approach genomic analysis, drug discovery, and personalized medicine. The use of AI algorithms and machine learning methods is leading to more accurate and efficient analysis, enabling better understanding of complex biological systems and paving the way for new therapeutic targets and treatments. The market is expected to continue growing at an impressive rate, outpacing traditional methods of data analysis and driving innovation in the life sciences industry.
What are the Key Data Covered in this AI In Omics Studies Market Research and Growth Report?
-
What is the expected growth of the AI In Omics Studies Market between 2025 and 2029?
-
USD 4 billion, at a CAGR of 34.2%
-
-
What segmentation does the market report cover?
-
The report is segmented by Type (Genomics, Transcriptomics, Proteomics, Metabolomics, and Epigenomics), Component (Software, Hardware, and Services), End-user (Pharmaceutical and biotech companies, Research centers, Healthcare providers, and Others), and Geography (North America, APAC, Europe, Middle East and Africa, and South America)
-
-
Which regions are analyzed in the report?
-
North America, APAC, Europe, Middle East and Africa, and South America
-
-
What are the key growth drivers and market challenges?
-
Technological advancements in AI and computational power, Intricacies of data complexity, standardization, and integration
-
-
Who are the major players in the AI In Omics Studies Market?
-
aiwell Inc., BenevolentAI, Biodesix Inc., Data4Cure Inc., Deep Genomics Inc., DNAnexus Inc., Engine Biosciences Pte.Ltd., Fabric Genomics Inc., FDNA Inc., Freenome Holdings Inc., Genoox, International Business Machines Corp., Invitae Corp., Lifebit Biotech Inc, Microsoft Corp., MolecularMatch Inc., NVIDIA Corp., PrecisionLife Ltd, SOPHiA GENETICS, and Verge Analytics Inc.
-
We can help! Our analysts can customize this ai in omics studies market research report to meet your requirements.